EUVIMEDEUVIMED entdecken
Crossref

RNA‐binding motif protein 24 inhibits HBV replication in vivo

Yong-Xuan Yao, Yingshan Chen, Dan Huang, Canyu Liu, Hao Sun, Yuan Zhou, Rongjuan Pei, Yun Wang, Zhe Wen, Bo Yang, Xinwen Chen iD

Journal of Medical Virology · 2023

DOI: 10.1002/jmv.28969 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2023. Verfasst von Yong-Xuan Yao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Joint Center of Translational Precision Medicine, Guangzhou Women and Children Medical Center, Guangzhou Institute of Pediatrics, Guangzhou, China. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Hepatitis B. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the extensive use of effective vaccines and antiviral drugs, chronic hepatitis B virus (HBV) infection continues to pose a serious threat to global public health. Therapies with novel mechanisms of action against HBV are being explored for achieving a functional cure. In this study, five murine models of HBV replication were used to investigate the inhibitory effect of RNA binding motif protein 24 (RBM24) on HBV replication. The findings revealed that RBM24 serves as a host restriction factor and suppresses HBV replication in vivo. The transient overexpression of RBM24 in hydrodynamics‐based mouse models of HBV replication driven by the CMV or HBV promoters suppressed HBV replication. Additionally, the ectopic expression of RBM24 decreased viral accumulation and the levels of HBV covalently closed circular DNA (cccDNA) in an rcccDNA mouse model. The liver‐directed transduction of adeno‐associated viruses (AAV)‐RBM24 mediated the stable hepatic expression of RBM24 in pAAV‐HBV1.2 and HBV/tg mouse models, and markedly reduced the levels of HBV cccDNA and other viral indicators. Altogether, these findings revealed that RBM24 inhibits the replication of HBV in vivo, and RBM24 may be a potential therapeutic target for combating HBV infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B, ChronicHepatitis BMiceAnimalsHepatitis B virusVirus ReplicationDNA, CircularRNA-Binding MotifsDNA, Viral

Stichwörter der Autor:innen

RNA binding motif protein 24adeno-associated virus vectorfunctional curehepatitis B virusreplication

Substanzen

DNA, CircularDNA, Viral

Autor:innen und Institutionen

  • Joint Center of Translational Precision Medicine, Guangzhou Women and Children Medical Center, Guangzhou Institute of Pediatrics, Guangzhou, China.
  • State Key Laboratory of Virology, Center for Biosafety Mega-Science, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.
  • Guangzhou Medical University, Guangzhou, China.
  • University of Chinese Academy of Sciences, Beijing, China.
  • GemPharmatech(Guangdong)Co., Ltd., Foshan, China.
  • Guangzhou Laboratory, Guangzhou, China.

ORCID-Profile: Xinwen Chen

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Yao, Y. X., Chen, Y., Huang, D., Liu, C., Sun, H., Zhou, Y., Pei, R., Wang, Y., Wen, Z., Yang, B., & Chen, X. (2023). RNA‐binding motif protein 24 inhibits HBV replication in vivo. Journal of Medical Virology. https://doi.org/10.1002/jmv.28969

Vancouver

Yao YX, Chen Y, Huang D, Liu C, Sun H, Zhou Y, et al. RNA‐binding motif protein 24 inhibits HBV replication in vivo. Journal of Medical Virology. 2023. doi:10.1002/jmv.28969

BibTeX
@article{Yao2023,
  author = {Yao, Yong-Xuan and Chen, Yingshan and Huang, Dan and Liu, Canyu and Sun, Hao and Zhou, Yuan and Pei, Rongjuan and Wang, Yun and Wen, Zhe and Yang, Bo and Chen, Xinwen},
  title = {RNA‐binding motif protein 24 inhibits HBV replication in vivo},
  journal = {Journal of Medical Virology},
  year = {2023},
  doi = {10.1002/jmv.28969}
}
Kostenlos starten →